Journal Club

HomeMembersAssemblies and SectionsAssembliesThoracic OncologyJournal Club ▶ Complication Rates and Downstream Medical Costs Associated With Invasive Diagnostic Procedures for Lung Abnormalities in the Community Setting
Complication Rates and Downstream Medical Costs Associated With Invasive Diagnostic Procedures for Lung Abnormalities in the Community Setting

Webinar date: March 7 at 2:00PM EDT

Presenters:

Arjan Flora, MD 
University of Cincinnati

Author:

Jinhai Stephen Huo, PhD, MD, MSPH
University of Florida

Discussant Panelists:

A. Cole Burks, MD
University of North Carolina – Chapel Hill

Gerard A. Silvestri, MD, MS
Medical University of South Carolina

Moderators:

Nichole Tanner, MD, MSCR
McGill University

Anne Gonzalez, MD, MSc
McGill University

Recommended Follow Up Reading:

Quality gaps and comparative effectiveness in lung cancer stagin gand diagnosis.  Ost DE, et al.  Chest. 2014 Feb;145(2):331-345. doi: 10.1378/chest.13-1599

The influence of hospital volume on survival after resection for lung cancer.  Bach PD, et al. N Engl J Med. 2001 Jul 19;345(3):181-8.

Components necessary for high-quality lung cnacer screening: American College of Chest Physician and American Thoracic Society Policy Statement.  Mazzone P, et al. Chest. 2015 Feb;147(2):295-303. doi: 10.1378/chest.14-2500.

Assessing the Generalizability of the National Lung Screening Trial: Comparison of Patients with Stage 1 Disease.  Tanner NT, et al.  Am J Respir Crit Care Med. 2017 Sep 1;196(5):602-608. doi: 10.1164/rccm.201705-0914OC.

Last Reviewed: March 2019